Medical cannabis addresses individual symptoms while supporting overall well-being; it offers a holistic health approach for chronic condition patients, focusing on restoring balance in the body and mind.
The market for medical cannabis in the UK is projected to exceed £23 million by the end of 2024, with active users expected to rise to over 337,000.
Patients report significant improvements such as enhanced physical comfort, decreased stress, and a revitalized quality of life, enabling them to reconnect with hobbies and enjoy daily activities.
Leading providers like Releaf and companies like Glass Pharms are pioneering a sustainable future for medical cannabis, driving economic growth through innovation and job creation.
Collection
[
|
...
]